SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following favorable FDA feedback for its lead drug, sonelokimab, enabling a Biologics License Application submission for multiple indications without additional trials. This news is driving widespread community speculation about an accelerated path to market and significant analyst upgrades. Investors are actively discussing the drug's "best-in-class" potential for inflammatory skin diseases, fueling conversations around short squeeze opportunities and potential buyout offers from major pharmaceutical companies.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing increased scrutiny following a price target trim by Goldman Sachs and ongoing market skepticism surrounding its potential acquisition of Warner Bros. Discovery. Community sentiment is sharply divided, with many expressing frustration over recent price declines and concerns about the WBD deal, while others view the current valuation as a compelling buying opportunity ahead of anticipated strong earnings results. Investors are closely watching for signs of strength and clarity, particularly with Q4 earnings approaching, which could prove pivotal for the stock's direction amidst persistent acquisition drama.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited is trending due to a recently announced significant private placement and plans to acquire a TikTok star-led e-commerce platform. The community is actively discussing the stock's extremely low float and potential for a short squeeze, drawing comparisons to other high-flying Hong Kong-based IPOs. This has ignited fervent trading, with some traders touting its 'unicorn' potential while others debate the sustainability of its rapid ascent.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending after its CEO met with a former president, who praised the company's commitment to U.S. chip manufacturing and its new advanced processors. The community is actively discussing the implications of this government backing, speculating on potential major partnerships and defense contracts, as Intel is viewed as a strategic national asset in the push for domestic semiconductor production.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is a focal point of investor discussion as the biotech community anticipates potential updates at the upcoming JP Morgan Healthcare Conference, with many expressing frustration over the stock's underperformance despite robust Briumvi sales and an active M&A environment. Conversations are heavily focused on Briumvi's strong market share growth and best-in-class profile, the significant potential of a future subcutaneous formulation, and persistent buyout speculation, especially as competing BTK inhibitors face recent setbacks.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending as widespread frustration mounts over warmer-than-expected winter weather forecasts, severely impacting natural gas demand. The community is vocal about significant losses, widely labeling the leveraged ETF a "widow maker" due to its inherent decay, while others debate a potential reversal, citing oversold conditions and the possibility of a polar vortex.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals is experiencing extreme volatility, fueled by a substantial special cash dividend and intense speculation around a potential pivot to blockchain assets. Community discussion is sharply divided between those anticipating a major short squeeze and turnaround driven by investor David Lazar's involvement, and others warning of a potential pump and dump given underlying fundamental concerns.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending due to recent government initiatives aimed at significantly lowering mortgage rates, including a substantial purchase of mortgage bonds, which has driven rates to their lowest in years and ignited optimism across the real estate sector. The community is actively discussing the potential for a continued rally and a gamma squeeze, with many anticipating further upside and cheering against short sellers as housing market activity is expected to surge.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is a major talking point following news of Amazon Pharmacy offering Novo Nordisk's oral GLP-1 weight-loss pill, intensifying competitive concerns for HIMS which does not offer the product. This development, alongside a recent analyst downgrade, is fueling a deeply divided community, with many anticipating further declines while bullish investors view the significant pullback as an overblown reaction and a strategic long-term buying opportunity in the evolving telehealth market.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is experiencing heightened investor interest due to recent U.S. actions regarding Venezuela's immense oil reserves, where President Trump has indicated American oil companies, particularly those with existing operations like Chevron, will be heavily involved in rebuilding the sector. The community is actively discussing whether Chevron's unique positioning offers a significant long-term growth opportunity or if the substantial infrastructure investments and political risks present formidable challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amazon quietly fixes the problems customers hate most

Every American has faced the maddening experience of bad customer service.My favorite example has always been Comcast, which, when you call their phone number to see why your internet is out, directs...

Reasons Why You Should Retain Paychex Stock in Your Portfolio

PAYX's growth is driven by rising SaaS adoption, the Paycor acquisition and AI launches, with FY26 revenues projected to rise 16.5% and earnings gains ahead.

Five9 (NASDAQ:FIVN) Raised to Strong-Buy at Zacks Research

Zacks Research upgraded shares of Five9 from a "hold" rating to a "strong-buy" rating in a research report on Monday...

FIVN vs. FFIV: Which Stock Is the Better Value Option?

Buy These 5 Small and Mid-Sized AI Stocks for Stellar Returns in 2026

Small- and mid-cap AI plays - PATH, FIVN, QLYS, TDC and BB lagged last year but could become game changers in 2026 as AI infrastructure demand stays bullish.


JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

JFrog Ltd. (Nasdaq: FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog...

Five9 (NASDAQ:FIVN) Trading Down 5.4% - Should You Sell?

Five9 (NASDAQ:FIVN) Shares Down 5.4% - Here's Why...

Itron Down 26% in the Past 3 Months: What Should Investors Do Now?

ITRI shares have slid 26% in three months as weak guidance, macro pressures and competition weigh on sentiment despite Grid Edge Intelligence momentum.

Onto Stock Surges 52% in the Past 6 Months: Will the Uptrend Continue?

ONTO shares have surged 51.8% in six months, driven by AI-driven advanced packaging demand, Dragonfly uptake, factory ramp-ups and accretive acquisitions.

Can Enterprise AI Adoption Boost FIVN's Growth Trajectory in 2026?

FIVN's enterprise AI bookings are surging as cloud contact centers shift to AI-orchestrated workflows, setting up stronger revenue momentum into 2026.

Five9, Inc. engages in the provision of cloud software for contact centers. It specializes in omnichannel routing, analytics, workforce organization, and reporting. The company was founded in December 2001 and is headquartered in San Ramon, CA.

Five9 Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$19.86
Prev Close	$19.90
Open	$19.94
Dividend Yield	0.00%
50-Day Moving Average	$20.58
Beta	1.56
Avg. Volume	1.66M
PE Ratio	55.90

52-Week High	$49.90
52-Week Low	$17.71
Market Capitalization	$1.56B
EPS (Annual)	-$0.1717
Price to Book	2.01
Revenue Per Employee	$339,062.15
Enterprise Value/EBITDA	N/A

FIVN
Five9 Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FIVN News

FIVNFive9 Inc